BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24898696)

  • 21. GOLPH3 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in epithelial ovarian cancer.
    Sun J; Yang X; Zhang R; Liu S; Gan X; Xi X; Zhang Z; Feng Y; Sun Y
    Cancer Med; 2017 Apr; 6(4):834-844. PubMed ID: 28332316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer.
    Badiglian Filho L; Oshima CT; De Oliveira Lima F; De Oliveira Costa H; De Sousa Damião R; Gomes TS; Gonçalves WJ
    Oncol Rep; 2009 Feb; 21(2):313-20. PubMed ID: 19148501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
    Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD133+ ovarian cancer stem-like cells promote non-stem cancer cell metastasis via CCL5 induced epithelial-mesenchymal transition.
    Long H; Xiang T; Qi W; Huang J; Chen J; He L; Liang Z; Guo B; Li Y; Xie R; Zhu B
    Oncotarget; 2015 Mar; 6(8):5846-59. PubMed ID: 25788271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host Wnt5a Potentiates Microenvironmental Regulation of Ovarian Cancer Metastasis.
    Asem M; Young AM; Oyama C; Claure De La Zerda A; Liu Y; Yang J; Hilliard TS; Johnson J; Harper EI; Guldner I; Zhang S; Page-Mayberry T; Kaliney WJ; Stack MS
    Cancer Res; 2020 Mar; 80(5):1156-1170. PubMed ID: 31932454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The involvement of RhoA and Wnt-5a in the tumorigenesis and progression of ovarian epithelial carcinoma.
    Chen S; Wang J; Gou WF; Xiu YL; Zheng HC; Zong ZH; Takano Y; Zhao Y
    Int J Mol Sci; 2013 Dec; 14(12):24187-99. PubMed ID: 24351810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emodin inhibits epithelial to mesenchymal transition in epithelial ovarian cancer cells by regulation of GSK-3β/β-catenin/ZEB1 signaling pathway.
    Hu C; Dong T; Li R; Lu J; Wei X; Liu P
    Oncol Rep; 2016 Apr; 35(4):2027-34. PubMed ID: 26820690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2.
    Wang L; Lin L; Chen X; Sun L; Liao Y; Huang N; Liao W
    Oncotarget; 2015 May; 6(13):11492-506. PubMed ID: 25895023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Abnormal Methylation of Wnt5a Gene Promoter Regions in Human Epithelial Ovarian Cancer: A Clinical and Experimental Study.
    Jin P; Song Y; Yu G
    Anal Cell Pathol (Amst); 2018; 2018():6567081. PubMed ID: 30079293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Crosstalk between Wnt signaling and Phorbol ester-mediated PKC signaling in MCF-7 human breast cancer cells.
    Kim S; Chun SY; Kwon YS; Nam KS
    Biomed Pharmacother; 2016 Feb; 77():114-9. PubMed ID: 26796274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wnt5a is required for endothelial differentiation of embryonic stem cells and vascularization via pathways involving both Wnt/beta-catenin and protein kinase Calpha.
    Yang DH; Yoon JY; Lee SH; Bryja V; Andersson ER; Arenas E; Kwon YG; Choi KY
    Circ Res; 2009 Feb; 104(3):372-9. PubMed ID: 19096028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Vasculogenic Mimicry Formation and CD133 Expression with Poor Prognosis in Ovarian Cancer.
    Liang J; Yang B; Cao Q; Wu X
    Gynecol Obstet Invest; 2016; 81(6):529-536. PubMed ID: 27160772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome.
    Leng R; Liao G; Wang H; Kuang J; Tang L
    Med Oncol; 2015 Feb; 32(2):329. PubMed ID: 25585684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II type 2 receptor-interacting protein 3a inhibits ovarian carcinoma metastasis via the extracellular HMGA2-mediated ERK/EMT pathway.
    Ping H; Guo L; Xi J; Wang D
    Tumour Biol; 2017 Jun; 39(6):1010428317713389. PubMed ID: 28651497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of X‑linked inhibitor of apoptosis‑associated factor‑1 in vasculogenic mimicry in ovarian cancer.
    Wang Y; Liu P; Wang X; Mao H
    Mol Med Rep; 2017 Jul; 16(1):325-330. PubMed ID: 28534973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition.
    Prasad CP; Chaurasiya SK; Guilmain W; Andersson T
    J Exp Clin Cancer Res; 2016 Sep; 35(1):144. PubMed ID: 27623766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical roles of Wnt5a-Ror2 signaling in aggressiveness of tongue squamous cell carcinoma and production of matrix metalloproteinase-2 via ΔNp63β-mediated epithelial-mesenchymal transition.
    Sakamoto T; Kawano S; Matsubara R; Goto Y; Jinno T; Maruse Y; Kaneko N; Hashiguchi Y; Hattori T; Tanaka S; Kitamura R; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Jun; 69():15-25. PubMed ID: 28559016
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual VEGF/PDGF knockdown suppresses vasculogenic mimicry formation in choroidal melanoma cells via the Wnt5a/β-catenin/AKT signaling pathway.
    Yuan Y; Geng B; Xu X; Zhao H; Bai J; Dou Z; Jia S; Yu X; Luo W
    Acta Histochem; 2022 Jan; 124(1):151842. PubMed ID: 34995928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ectopic repression of receptor tyrosine kinase-like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial-mesenchymal transition.
    Xu Y; Ma YH; Pang YX; Zhao Z; Lu JJ; Mao HL; Liu PS
    Tumour Biol; 2017 May; 39(5):1010428317701627. PubMed ID: 28475014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.